Transdermal Delivery of Luteinizing Hormone-releasing Hormone with Chitosan Microneedles: A promising tool for androgen deprivation therapy

Ming Yang Chen, Yi Ying Chen, Hsin Tzu Tsai, Tzong Shin Tzai, Mei Chin Chen, Yuh Shyan Tsai

研究成果: Article

2 引文 (Scopus)

摘要

Long-term administration of luteinizing hormone-releasing hormone analogs (LHRHa) is the main type of androgen-deprivation therapy (ADT) for lethal prostate cancer. A fully insertable microneedle system, composed of embeddable chitosan microneedles and a dissolvable polyvinyl alcohol/polyvinyl pyrrolidone supporting array, was developed for sustained delivery of LHRHa to the skin. A porcine cadaver skin test showed that chitosan microneedles can be fully embedded within the skin and microneedle-created micropores reseal within 7 days. The measured LHRHa loading amount was 73.3±2.8 μg per microneedle patch. After applying goserelin-containing microneedles to mice, serum LH levels increased initially and then declined below baseline at day 7. In contrast, serum testosterone levels increased to reach a peak at day 14 and then declined to a castration level at day 21. Additionally, such a castration level was maintained for 2 weeks. Therefore, transdermal delivery of goserelin with embeddable chitosan microneedles can produce a castrated state in mice. Such a system is a promising, feasible means of delivering ADT.

原文English
頁(從 - 到)6791-6797
頁數7
期刊Anticancer research
37
發行號12
DOIs
出版狀態Published - 2017 一月 1

指紋

Chitosan
Goserelin
Gonadotropin-Releasing Hormone
Androgens
Castration
Polyvinyls
Pyrrolidinones
Polyvinyl Alcohol
Skin
Skin Tests
Serum
Cadaver
Testosterone
Prostatic Neoplasms
Swine
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

引用此文

@article{95790d2c75264f0880a1b213f0b2bf54,
title = "Transdermal Delivery of Luteinizing Hormone-releasing Hormone with Chitosan Microneedles: A promising tool for androgen deprivation therapy",
abstract = "Long-term administration of luteinizing hormone-releasing hormone analogs (LHRHa) is the main type of androgen-deprivation therapy (ADT) for lethal prostate cancer. A fully insertable microneedle system, composed of embeddable chitosan microneedles and a dissolvable polyvinyl alcohol/polyvinyl pyrrolidone supporting array, was developed for sustained delivery of LHRHa to the skin. A porcine cadaver skin test showed that chitosan microneedles can be fully embedded within the skin and microneedle-created micropores reseal within 7 days. The measured LHRHa loading amount was 73.3±2.8 μg per microneedle patch. After applying goserelin-containing microneedles to mice, serum LH levels increased initially and then declined below baseline at day 7. In contrast, serum testosterone levels increased to reach a peak at day 14 and then declined to a castration level at day 21. Additionally, such a castration level was maintained for 2 weeks. Therefore, transdermal delivery of goserelin with embeddable chitosan microneedles can produce a castrated state in mice. Such a system is a promising, feasible means of delivering ADT.",
author = "Chen, {Ming Yang} and Chen, {Yi Ying} and Tsai, {Hsin Tzu} and Tzai, {Tzong Shin} and Chen, {Mei Chin} and Tsai, {Yuh Shyan}",
year = "2017",
month = "1",
day = "1",
doi = "10.21873/anticanres.12139",
language = "English",
volume = "37",
pages = "6791--6797",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "12",

}

Transdermal Delivery of Luteinizing Hormone-releasing Hormone with Chitosan Microneedles : A promising tool for androgen deprivation therapy. / Chen, Ming Yang; Chen, Yi Ying; Tsai, Hsin Tzu; Tzai, Tzong Shin; Chen, Mei Chin; Tsai, Yuh Shyan.

於: Anticancer research, 卷 37, 編號 12, 01.01.2017, p. 6791-6797.

研究成果: Article

TY - JOUR

T1 - Transdermal Delivery of Luteinizing Hormone-releasing Hormone with Chitosan Microneedles

T2 - A promising tool for androgen deprivation therapy

AU - Chen, Ming Yang

AU - Chen, Yi Ying

AU - Tsai, Hsin Tzu

AU - Tzai, Tzong Shin

AU - Chen, Mei Chin

AU - Tsai, Yuh Shyan

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Long-term administration of luteinizing hormone-releasing hormone analogs (LHRHa) is the main type of androgen-deprivation therapy (ADT) for lethal prostate cancer. A fully insertable microneedle system, composed of embeddable chitosan microneedles and a dissolvable polyvinyl alcohol/polyvinyl pyrrolidone supporting array, was developed for sustained delivery of LHRHa to the skin. A porcine cadaver skin test showed that chitosan microneedles can be fully embedded within the skin and microneedle-created micropores reseal within 7 days. The measured LHRHa loading amount was 73.3±2.8 μg per microneedle patch. After applying goserelin-containing microneedles to mice, serum LH levels increased initially and then declined below baseline at day 7. In contrast, serum testosterone levels increased to reach a peak at day 14 and then declined to a castration level at day 21. Additionally, such a castration level was maintained for 2 weeks. Therefore, transdermal delivery of goserelin with embeddable chitosan microneedles can produce a castrated state in mice. Such a system is a promising, feasible means of delivering ADT.

AB - Long-term administration of luteinizing hormone-releasing hormone analogs (LHRHa) is the main type of androgen-deprivation therapy (ADT) for lethal prostate cancer. A fully insertable microneedle system, composed of embeddable chitosan microneedles and a dissolvable polyvinyl alcohol/polyvinyl pyrrolidone supporting array, was developed for sustained delivery of LHRHa to the skin. A porcine cadaver skin test showed that chitosan microneedles can be fully embedded within the skin and microneedle-created micropores reseal within 7 days. The measured LHRHa loading amount was 73.3±2.8 μg per microneedle patch. After applying goserelin-containing microneedles to mice, serum LH levels increased initially and then declined below baseline at day 7. In contrast, serum testosterone levels increased to reach a peak at day 14 and then declined to a castration level at day 21. Additionally, such a castration level was maintained for 2 weeks. Therefore, transdermal delivery of goserelin with embeddable chitosan microneedles can produce a castrated state in mice. Such a system is a promising, feasible means of delivering ADT.

UR - http://www.scopus.com/inward/record.url?scp=85038378736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038378736&partnerID=8YFLogxK

U2 - 10.21873/anticanres.12139

DO - 10.21873/anticanres.12139

M3 - Article

C2 - 29187457

AN - SCOPUS:85038378736

VL - 37

SP - 6791

EP - 6797

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 12

ER -